Brooklyn, New York, Jan. 10, 2023 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global mRNA Vaccines Market is projected to grow at a CAGR of 13.03% from 2023 to 2028.
Due to advanced medical technologies, higher quality of services, efficiency, and novel pharmaceutical innovations, the market is estimated to drive during the forecast period. There is also a rise in demand for gene therapies, an extreme increase in chronic and infectious diseases, and an increase in cancer therapy, which will propel the mRNA vaccine market growth.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC on “Global MRNA Vaccines Market - Forecast to 2028’’
Key Market Insights
- As per the application outlook, the cancer segment is expected to be the largest segment in the global mRNA vaccines market from 2023 to 2028
- As per the end-use outlook, the hospitals & clinics segment is expected to be the largest segment in the global mRNA vaccines market from 2023 to 2028
- The Asia Pacific region is analyzed to be the fastest-growing segment in the market
- North America region will have the largest share in the market during the forecast period of 2023-2028
- Argos Therapeutics Inc., BioNTech AG, CureVac AG, ETheRNA Immunotherapies, Ethris GmbH, Incellart, Moderna Inc., Sangamo Therapeutics Inc., Tiba Biotech, and Translate Bio Inc. among others, are some of the key players in the mRNA vaccines market
Request a Sample Copy of the Report @ https://www.globalmarketestimates.com/market-report/mrna-vaccines-market
Application Mode Outlook (Revenue, USD Billion, 2023-2028)
- HIV-AIDS
- Cancer
- Respiratory Diseases
- Others
End-User Outlook (Revenue, USD Billion, 2023-2028)
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
Regional Outlook (Revenue, USD Billion, 2023-2028)
North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Netherlands
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Thailand
- Indonesia
- Malaysia
- Singapore
- Vietnam
- Rest of APAC
Central & South America
- Brazil
- Argentina
- Chile
- Rest of CSA
Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of MEA
Contact: Yash Jain
Director - Global Accounts & Strategic Advisory
Email address: yash.jain@globalmarketestimates.com
Phone Number: +1 6026667238
Website: www.globalmarketestimates.com
